Company Filing History:
Years Active: 2023
Title: The Innovations of Inventor Daniel Goetz
Introduction: Daniel Goetz, an accomplished inventor based in Duesseldorf, Germany, has made notable contributions to the field of pharmaceutical chemistry. With a focus on innovative methods, Goetz holds a patent that demonstrates his commitment to advancing technology and science in effective drug formulation.
Latest Patents: Goetz's patent outlines a preparative process for synthesizing specific compounds, including 4-{[(2S)-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl]amino}-2-fluorobenzamide and its related analogues. This innovative process involves the use of various chemical precursors, highlighting Goetz’s expertise in complex organic synthesis.
Career Highlights: Daniel Goetz is associated with Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company renowned for its commitment to research and development of innovative medical solutions. His role at Bayer has allowed him to play a significant part in advancing pharmaceutical technology through his inventive work.
Collaborations: Throughout his career, Daniel has collaborated with notable colleagues, including Julian Egger and Michal Sowa. These collaborations have fostered a dynamic environment for innovation and have contributed to the successful development and refinement of Goetz's patent processes.
Conclusion: As a prominent figure in the field of inventing, Daniel Goetz exemplifies the spirit of innovation within the pharmaceutical industry. His dedication to developing novel processes and collaboration with esteemed colleagues continues to impact the landscape of pharmaceutical advancements.